Holen Sie sich die Stockscreener-App
36.50
0.88%
0.32
Handel nachbörslich:
36.50
Schlusskurs vom Vortag:
$36.18
Offen:
$36.2
24-Stunden-Volumen:
531.70K
Relative Volume:
0.88
Marktkapitalisierung:
$1.64B
Einnahmen:
$1.15B
Nettoeinkommen (Verlust:
$23.09M
KGV:
73.00
EPS:
0.5
Netto-Cashflow:
$89.18M
1W Leistung:
-1.54%
1M Leistung:
-28.97%
6M Leistung:
+16.46%
1J Leistung:
-9.26%
1-Tages-Spanne:
$36.18
$37.04
1-Wochen-Bereich:
$35.38
$39.46
52-Wochen-Spanne:
$22.66
$55.00
Omnicell Inc Stock (OMCL) Company Profile
Firmenname
Omnicell Inc
Sektor
Branche
Telefon
(877) 415-9990
Adresse
4220 NORTH FREEWAY, FORT WORTH
Compare OMCL vs VEEV, TEM, BTSG, HQY, DOCS
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OMCL
Omnicell Inc
|
36.50 | 1.62B | 1.15B | 23.09M | 89.18M | 0.50 |
|
VEEV
Veeva Systems Inc
|
174.11 | 28.27B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
51.95 | 9.03B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
BTSG
Brightspring Health Services Inc
|
38.86 | 6.82B | 11.99B | 24.18M | 234.31M | 0.2956 |
|
HQY
Healthequity Inc
|
73.88 | 6.25B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
25.02 | 4.56B | 550.17M | 201.35M | 232.07M | 1.00 |
Omnicell Inc Stock (OMCL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-04 | Hochstufung | BofA Securities | Neutral → Buy |
| 2026-01-08 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-05-14 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-10-31 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-08-02 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2024-01-03 | Eingeleitet | Barclays | Underweight |
| 2023-11-03 | Herabstufung | BTIG Research | Buy → Neutral |
| 2023-11-03 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2023-11-03 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2023-10-11 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-09-26 | Bestätigt | Wells Fargo | Underweight |
| 2023-08-02 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2023-07-20 | Herabstufung | Wells Fargo | Overweight → Underweight |
| 2023-02-27 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2022-11-03 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2022-09-09 | Eingeleitet | BofA Securities | Buy |
| 2022-07-15 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2021-12-06 | Fortgesetzt | Wells Fargo | Overweight |
| 2021-06-09 | Eingeleitet | JP Morgan | Neutral |
| 2021-05-24 | Eingeleitet | BTIG Research | Buy |
| 2021-02-02 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2020-12-08 | Eingeleitet | Berenberg | Buy |
| 2020-12-03 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2020-07-07 | Eingeleitet | Stephens | Overweight |
| 2020-02-07 | Bestätigt | Dougherty & Company | Buy |
| 2019-11-21 | Bestätigt | Dougherty & Company | Buy |
| 2019-07-26 | Hochstufung | Craig Hallum | Hold → Buy |
| 2019-03-07 | Bestätigt | Dougherty & Company | Buy |
| 2018-06-29 | Fortgesetzt | The Benchmark Company | Buy |
| 2017-09-05 | Bestätigt | The Benchmark Company | Buy |
| 2017-07-28 | Bestätigt | Dougherty & Company | Buy |
| 2017-04-21 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2017-01-19 | Eingeleitet | Dougherty & Company | Buy |
| 2016-12-06 | Bestätigt | The Benchmark Company | Buy |
| 2016-07-07 | Bestätigt | FBR Capital | Outperform |
| 2016-03-21 | Bestätigt | Topeka Capital Markets | Buy |
| 2016-01-07 | Eingeleitet | The Benchmark Company | Buy |
| 2015-11-16 | Bestätigt | Topeka Capital Markets | Buy |
| 2015-10-30 | Bestätigt | FBR Capital | Outperform |
| 2015-09-28 | Hochstufung | Sidoti | Neutral → Buy |
| 2015-07-31 | Bestätigt | Topeka Capital Markets | Buy |
Alle ansehen
Omnicell Inc Aktie (OMCL) Neueste Nachrichten
Reasons to add Omnicell stock to your portfolio right now - MSN
Smart Medicine Compounding Robot Market Is Going to Boom | ARxIUM - openPR.com
Omnicell (OMCL) Is Down 19.0% After Profit Squeeze Despite Solid 2026 Revenue OutlookWhat's Changed - Yahoo Finance
Little Excitement Around Omnicell, Inc.'s (NASDAQ:OMCL) Revenues As Shares Take 26% Pounding - 富途牛牛
The Top 5 Analyst Questions From Omnicell's Q4 Earnings Call - Finviz
The Top 5 Analyst Questions From Omnicell’s Q4 Earnings Call - Yahoo Finance
Omnicell (NASDAQ:OMCL) Cut to Strong Sell at Zacks Research - MarketBeat
Omnicell, Inc. (OMCL) Stock Analysis: Unpacking a Potential 57% Upside in Healthcare Automation - DirectorsTalk Interviews
Omnicell (OMCL) Q4 2025 Earnings Call Transcript - AOL.com
Omnicell: Solid Execution and Strategic Promise Offset by Near-Term Profitability Pressures and Premium Valuation (Hold Rating Maintained) - TipRanks
Omnicell upgraded at BofA on buying opportunity ahead of Q4 results - MSN
Omnicell (OMCL) Margin Squeeze To 0.2% Net Profit Tests Bullish Recovery Narratives - Sahm
Analysts Conflicted on These Healthcare Names: Cigna (CI), Hims & Hers Health (HIMS) and Omnicell (OMCL) - The Globe and Mail
Omnicell (NASDAQ:OMCL) Downgraded to "Hold" Rating by Wall Street Zen - MarketBeat
Omnicell Earnings Call: Growth Intact, Margins Under Strain - TipRanks
Omnicell, Inc. (NASDAQ:OMCL) Q4 2025 Earnings Call Transcript - Insider Monkey
Omnicell (NASDAQ:OMCL) Stock Price Down 4.2% on Disappointing Earnings - MarketBeat
Analyst Jessica Tassan Lowers Omnicell (OMCL) Price Target to $4 - GuruFocus
Omnicell Q4 2025 Earnings: Stock Dives on Missed EPS, 2026 GuidanceNews and Statistics - IndexBox
Omnicell Stock Pre-Market (-15%) : Q4 EPS Miss & Weak 2026 Guidance - Trefis
Pharmacy Automation Systems Market Set for Explosive Growth - openPR.com
OMCL Q4 Deep Dive: Product Launches, Tariff Headwinds, and Margin Pressures Shape Outlook - Finviz
Omnicell Stock Pre-Market (+15%): Raises FY26 Guidance on Strong Titan XT Adoption - Trefis
Omnicell Q4 Earnings Call Highlights - MarketBeat
Omnicell targets $1.215B–$1.255B 2026 revenue as Titan XT and OmniSphere fuel platform push - MSN
Omnicell Q4 2025 slides: EPS miss drives 15% stock drop despite revenue growth - Investing.com Nigeria
Omnicell Inc (OMCL) Q4 2025 Earnings Call Highlights: Strong Dem - GuruFocus
Omnicell Inc (OMCL) Q4 2025 Earnings Call Highlights: Strong Demand and Strategic Innovations ... By GuruFocus - Investing.com Canada
Omnicell (NASDAQ:OMCL) Releases Quarterly Earnings Results, Misses Estimates By $0.07 EPS - MarketBeat
Assessing Omnicell (OMCL) Valuation After Recent Share Price Gains And High P/E Multiple - Yahoo Finance
Omnicell Announces Fiscal Year and Fourth Quarter 2025 Financial Results - BioSpace
Why Omnicell (OMCL) Shares Are Plunging Today - Finviz
Oversold Conditions For Omnicell (OMCL) - Nasdaq
Omnicell’s Strategic Pivot Meets Near-Term Profit Pressure - AD HOC NEWS
Earnings call transcript: Omnicell Q4 2025 misses EPS forecast, shares drop - Investing.com Nigeria
Omnicell (NASDAQ:OMCL) Shares Gap Down Following Weak Earnings - MarketBeat
Omnicell earnings: What to look for from OMCL - MSN
Omnicell (NASDAQ:OMCL) Updates FY 2026 Earnings Guidance - MarketBeat
Omnicell (NASDAQ:OMCL) Updates Q1 2026 Earnings Guidance - MarketBeat
Omnicell's (NASDAQ:OMCL) Q4 CY2025 Earnings Results: Revenue In Line With Expectations - Finviz
Omnicell (OMCL) Q4 Earnings Miss, Revenue Surpasses Expectations - GuruFocus
Omnicell Q4 Non-GAAP Net Income Falls, Revenue Rises; 2026 Guidance Issued - marketscreener.com
Omnicell (OMCL) Q4 Earnings Lag Estimates - Yahoo Finance
Omnicell: Fourth Quarter Financial Highlights - Bitget
(OMCL) Omnicell, Inc. Expects Q1 Revenue Range $300.0M$310.0M - marketscreener.com
(OMCL) Omnicell, Inc. Expects Q1 Adjusted EPS Range $0.26$0.36 - marketscreener.com
Omnicell: Q4 Earnings Snapshot - kare11.com
OMNICELL ($OMCL) Releases Q4 2025 Earnings - Quiver Quantitative
Omnicell’s (NASDAQ:OMCL) Q4 CY2025 Earnings Results: Revenue In Line With Expectations - Yahoo Finance
Omnicell stock upgraded at Bank of America (OMCL:NASDAQ) - Seeking Alpha
Omnicell stock rating upgraded by BofA Securities on Titan XT launch potential - Investing.com Canada
Finanzdaten der Omnicell Inc-Aktie (OMCL)
Umsatz
Nettogewinn
Free Cashflow
ENV
8.14%
3.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):